# Ketorolac Applied by Continuous IV Infusion for Treatment of Moderately Severe Postoperative Pain Following Bunionectomy

> **NCT05324358** · PHASE3 · SUSPENDED · sponsor: **Neumentum, Inc.** · enrollment: 341 (actual)

## Conditions studied

- Pain, Postoperative

## Interventions

- **DRUG:** Ketorolac Tromethamine
- **DRUG:** Morphine Sulfate
- **OTHER:** Intravenous Placebo for NTM-001
- **OTHER:** IV Placebo for Morphine

## Key facts

- **NCT ID:** NCT05324358
- **Lead sponsor:** Neumentum, Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2022-12-14
- **Primary completion:** 2024-09-06
- **Final completion:** 2027-05
- **Target enrollment:** 341 (ACTUAL)
- **Why stopped:** Study activities were suspended due to funding constraints after enrollment completion (N=340). Remaining activities, including data cleaning, database lock, analysis, and reporting, will resume once funding is secured.
- **Last updated:** 2026-04-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05324358

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05324358, "Ketorolac Applied by Continuous IV Infusion for Treatment of Moderately Severe Postoperative Pain Following Bunionectomy". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05324358. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*